Dexcel Pharma Technologies Ltd.
- SEC CIK
- 0001720007
No open-market purchases or sales filed in the past year.
Current role at each company
- ROIV Roivant Sciences Ltd.10% Owneras of Nov 14, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Dexcel Pharma Technologies Ltd. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 14, 2022 (view filing)8:40 AM ET | Nov 10 | 4 days | Dexxon Holdings Ltd. and 2 others10% Owner | PPurchase | +4.00M | $5.00 | +$20.0M | +4.0%102.8M after | |
| Apr 26, 2022 (view filing)6:48 AM ET | Apr 22-25 | 4 days | Dexxon Holdings Ltd. and 2 others10% Owner | PPurchase | +40.3K | $3.85 | +$155.0K | 0.0%98.8M after | 2 lots |